Voltar
Artigo Revisado por pares
BIBTEX RIS

Percutaneous patent foramen ovale and atrial septal defect closure in adults: Results and device comparison in 100 consecutive implants at a single center

2005; Wiley; Volume: 64; Issue: 2 Linguagem: Inglês

10.1002/ccd.20260

ISSN

1522-726X

Autores

Howard C. Herrmann, Frank E. Silvestry, Ruchira Glaser, Vincent See, Scott E. Kasner, Danielle Bradbury, Gene Chang, John W. Hirshfeld, Phillip A. Horwitz, Martin Kelly,

Tópico(s)

Respiratory Support and Mechanisms

Resumo

Catheterization and Cardiovascular InterventionsVolume 64, Issue 2 p. 197-203 Pediatric and Congenital Heart Disease Percutaneous patent foramen ovale and atrial septal defect closure in adults: Results and device comparison in 100 consecutive implants at a single center Howard C. Herrmann MD, Corresponding Author Howard C. Herrmann MD [email protected] Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaHospital of the University of Pennsylvania, 3400 Spruce Street, 9 Founders Pavilion, Philadelphia, PA 19104Search for more papers by this authorFrank E. Silvestry MD, Frank E. Silvestry MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorRuchira Glaser MD, Ruchira Glaser MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorVincent See MD, Vincent See MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorScott Kasner MD, Scott Kasner MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorDanielle Bradbury, Danielle Bradbury Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorGene Chang MD, Gene Chang MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorJohn W. Hirshfeld Jr. MD, John W. Hirshfeld Jr. MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorPhillip A. Horwitz MD, Phillip A. Horwitz MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorMichael Kelly MD, Michael Kelly MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this author Howard C. Herrmann MD, Corresponding Author Howard C. Herrmann MD [email protected] Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaHospital of the University of Pennsylvania, 3400 Spruce Street, 9 Founders Pavilion, Philadelphia, PA 19104Search for more papers by this authorFrank E. Silvestry MD, Frank E. Silvestry MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorRuchira Glaser MD, Ruchira Glaser MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorVincent See MD, Vincent See MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorScott Kasner MD, Scott Kasner MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorDanielle Bradbury, Danielle Bradbury Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorGene Chang MD, Gene Chang MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorJohn W. Hirshfeld Jr. MD, John W. Hirshfeld Jr. MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorPhillip A. Horwitz MD, Phillip A. Horwitz MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this authorMichael Kelly MD, Michael Kelly MD Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaSearch for more papers by this author First published: 27 January 2005 https://doi.org/10.1002/ccd.20260Citations: 27Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Abstract Closure of interatrial septal defects with percutaneous devices is increasingly common. However, the indications for closure and techniques for device implantation are diverse. We reviewed our first 100 consecutive implants to assess and compare the indications, results, complications, and evolution of techniques for percutaneous patent foramen ovale (PFO) and atrial septal defect (ASD) closure. The mean age of patients was 52 years and 70% were female. Paradoxical embolism was the predominant indication (94%) for PFO closure and significant left-to-right shunt was the most frequent indication (89%) for ASD closure. Implantation success was 94% with major complications in 3 patients (2.8%). Transesophageal echocardiography was utilized in the initial 27 procedures and then replaced by intracardiac echocardiography in subsequent ones, with an associated reduction in procedure and physician time. During 6 months of follow-up, 3 patients were readmitted for atrial arrhythmias (2 patients) and an MRI-negative neurologic event (1 patient). Echocardiography at 6 months in 83% of the PFO patients revealed moderate and severe positive contrast studies for right-to-left shunting in one third of patients, with differences between devices and insertion techniques. This single-center experience with percutaneous device closure of PFO and ASD in adults demonstrates excellent results with few complications. Catheter Cardiovasc Interv 2005;64:197–203. © 2005 Wiley-Liss, Inc. REFERENCES 1 Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003; 107: 5–9. 10.1161/01.CIR.0000046073.34261.C1 PubMedWeb of Science®Google Scholar 2 Hijazi ZM. Device closure of ventricular septal defects. Catheter Cardiovasc Interv 2003; 60: 107–114. 10.1002/ccd.10567 PubMedWeb of Science®Google Scholar 3 Hijazi ZM, Wang Z, Cao QL, Koenig P, Waight D, Lang R. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance. Catheter Cardiovasc Interv 2001; 52: 194–199. 10.1002/1522-726X(200102)52:2 3.0.CO;2-4 CASPubMedWeb of Science®Google Scholar 4 Demkow M, Ruzyllo W, Konka M, Kepka C, Kowalski M, Wilczynski J, Rydlewska-Sadowska W. Transvenous closure of moderate and large secundum atrial septal defects in adults using the Amplatzer septal occlude. Catheter Cardiovasc Interv 2001; 52: 188–193. 10.1002/1522-726X(200102)52:2 3.0.CO;2-6 CASPubMedWeb of Science®Google Scholar 5 Cao QL, Du ZD, Joseph A, Koenig P, Heitschmidt M, Rhodes J, Hijazi ZM. Immediate and six-month results of the profile of the Amplater septal occluder as assessed by transesophageal echocardiography. Am J Cardiol 2001; 88: 754–759. 10.1016/S0002-9149(01)01846-X CASPubMedWeb of Science®Google Scholar 6 Harper RW, Mottram PM, McGraw DT. Closure of secundum atrial septal defects with the Amplatzer septal occluder device: techniques and problems. Catheter Cardiovasc Interv 2002; 57: 508–524. 10.1002/ccd.10353 PubMedWeb of Science®Google Scholar 7 Riuz LE, Alboliras ET, Pophal SG. The puncture technique: a new method for transcatheter closure of patent foramen ovale. Catheter Cardiovas Interv 2001; 53: 369–372. 10.1002/ccd.1183 Web of Science®Google Scholar 8 Bartel T, Konorza T, Arjumand J, Ebradlidze T, Eggebrecht H, Caspari G, Neudorf U, Erbel R. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation 2003; 107: 795–797. 10.1161/01.CIR.0000057547.00909.1C PubMedWeb of Science®Google Scholar 9 Licata A, Herrmann HC, Kostacos EJ, See VY, Horwitz PA, Hirshfeld JW, Wiegers SE, St John Sutton M, Silvestry FE. Benefits of intracardiac echocardiography in the guidance of percutaneous transcatheter closure of atrial septal defect and patent foramen ovale. J Am Coll Cardiol 2003; 41( Suppl A): 60A. 10.1016/S0735-1097(03)80875-6 Web of Science®Google Scholar 10 Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism. Circulation 2002; 105: 2845–2848. 10.1161/01.CIR.0000019069.32964.0E PubMedWeb of Science®Google Scholar 11 Martin F, Sanchecz PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonamo F, Demirjian Z, deMoor M, Polacios IF. Percutaneous transcatheter closure of patent foraman ovale in patients with paradoxical embolism. Circulation 2002; 106: 1121–1126. 10.1161/01.CIR.0000027819.19722.EE PubMedWeb of Science®Google Scholar 12 Braun MU, Fassbenden D, Schoer SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002; 39: 2019–2025. 10.1016/S0735-1097(02)01904-6 CASPubMedWeb of Science®Google Scholar 13 Mas JL, Arquizon C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740–1746. 10.1056/NEJMoa011503 CASPubMedWeb of Science®Google Scholar 14 Mohr JP, Thompson JLP, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444–1451. 10.1056/NEJMoa011258 CASPubMedWeb of Science®Google Scholar 15 Homma S, Sacco RL, DiTullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patient foramen ovale. Circulation 2002; 105: 2625–2631. 10.1161/01.CIR.0000017498.88393.44 PubMedWeb of Science®Google Scholar 16 Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002; 39: 2019–2025. 10.1016/S0735-1097(02)01904-6 CASPubMedWeb of Science®Google Scholar 17 Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King MEE, Buonanno F, Demirjian Z, deMoor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002; 106: 1121–1126. 10.1161/01.CIR.0000027819.19722.EE PubMedWeb of Science®Google Scholar 18 Veldtman GR, Razack V, Siu S, El-Hajj H, Walker F, Webb GD, Benson LN, McLaughlin PR. Right ventricular form and function after percutaneous atrial septal defect closure. J Am Coll Cardiol 2001; 37: 2108–2113. Google Scholar 19 Brochu MC, Baril JF, Dore A, Juneau M, DeGuise P, Mercier LA. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect closure. Circulation 2002; 106: 1821–1826. 10.1161/01.CIR.0000029924.90823.E0 PubMedWeb of Science®Google Scholar 20 Abdul Wahal H, Bairam AR, Cao QL, Hijazi ZM. Novel technique to prevent prolapse of the Amplatzer septal occluder through large atrial septal defect. Catheter Cardiovasc Interv 2003; 60: 543–545. 10.1002/ccd.10686 PubMedWeb of Science®Google Scholar 21 Ren JF, Marchlinski FE, Callans DJ, Herrmann HC. Clinical use of acunav diagnostic ultrasound catheter imaging during left heart radiofrequency ablation and transcatheter closure procedures. J Am Soc Echocardiogr 2002; 15: 1301–1308. 10.1067/mje.2002.124646 PubMedWeb of Science®Google Scholar 22 Schwerzmann M, Seiler C, Lipp E, Guzman R, Lovblad KO, Kraus M, Kucho N. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Am Intern Med 2001; 134: 21–24. 10.7326/0003-4819-134-1-200101020-00009 CASPubMedWeb of Science®Google Scholar 23 Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 2356: 1648–1651. 10.1016/S0140-6736(00)03160-3 Web of Science®Google Scholar 24 Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H, Seiler C, Meier B. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004; 90: 186–190. 10.1136/hrt.2002.003111 CASPubMedWeb of Science®Google Scholar 25 Jux C, Wohlsein P, Bruegmann M, Zutz M, Franzbach B, Bertram H. A new biological matrix for septal occlusion. J Interv Cardiol 2003; 16: 149–152. 10.1046/j.1540-8183.2003.08027.x PubMedGoogle Scholar Citing Literature Volume64, Issue2February 2005Pages 197-203 SCAI Member Sign in ReferencesRelatedInformation

Referência(s)